Wuxi biologics granted highest negligible-risk esg rating from morningstar sustainalytics

Best esg rating tier of negligible-risk with a top 1% global ranking score industry and regional esg top-rated company for five consecutive years leader in green crdmo to drive innovation for a healthier future shanghai , july 16, 2025 /prnewswire/ -- wuxi biologics (2269.hk), a leading global contract research, development, and manufacturing organization (crdmo), today announced it has elevated its morningstar sustainalytics esg rating score to the highest negligible-risk tier, demonstrating its leadership in the global pharmaceutical industry. sustainalytics is a leading esg data, research, and ratings firm that supports global investors with their development and implementation of responsible investment strategies.
MORN Ratings Summary
MORN Quant Ranking